Adalimumab-Pfizer
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adalimumab-Pfizer, covering 2017-09-26 to 2017-09-26. Get the full timeline:
Most recent: Clinical Trial Update: A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02). [Phase 3]